AlphaStocks

ELV vs VAL

As of Sep 20, 2026, Elevance Health (ELV) scores 6.3/10 and Valaris (VAL) 4.6/10 on AlphaStocks' five-model composite, so ELV scores higher. ELV trades 30% below its model fair value.

ELV

Elevance Health, Inc.

6.3

Consider Buy

$410.92

VAL

Valaris Ltd

4.6

Weak

$83.77

ELV vs VAL: Which is the Better Investment?

Elevance Health, Inc. (ELV) scores 6.3/10 while Valaris Ltd (VAL) scores 4.6/10 on AlphaStocks' composite model. Elevance Health, Inc. has the higher composite rating of Consider Buy. On a P/E basis, Valaris Ltd trades at 6.0x, making it the more attractively priced of the two.

This comparison is algorithmically generated and is not financial advice.

MetricELVVAL
Scores & Fundamentals
Composite Score6.3/104.6/10
RatingConsider BuyWeak
Price$410.92$83.77
P/E Ratio16.36.0
ROE12.9%35.0%
Market Cap$91B$6B
Fair Value$587.51
Dividend Yield1.7%
Sector Rank#34 of 168#38 of 80
Model Verdicts
PiotroskiAttractiveStrong
BuffettNeutralAttractive
GrahamCautionNeutral
LynchNeutralNeutral
GreenblattAttractiveAttractive
View full ELVanalysis →View full VALanalysis →

Related comparisons

Compare any two stocks →

ELV vs VAL: Which Stock Scores Higher?

Elevance Health, Inc. (ELV) is in the Health Care sector; Valaris Ltd (VAL) is in Energy. ELV currently leads with a composite score of 6.3/10 (Consider Buy) compared to VAL's 4.6/10 (Weak).

The AlphaStocks composite score evaluates each stock across four dimensions: Quality (business strength measured by Piotroski F-Score and Buffett quality criteria), Value (discount to intrinsic worth using Graham, Lynch, and Greenblatt models), Momentum (6-month price trend), and Timing (a confirmation signal that requires both value and momentum to align). A higher composite score indicates stronger overall fundamentals combined with favorable market conditions.

This comparison uses the same scoring framework for both companies, ensuring an apples-to-apples evaluation. Scores are recalculated daily after market close using data from SEC filings and market prices. Read the full methodology to understand how each model contributes to the composite score.

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer